Invention Grant
- Patent Title: 1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof
-
Application No.: US15528435Application Date: 2015-11-17
-
Publication No.: US09951040B2Publication Date: 2018-04-24
- Inventor: Thanusha Thatikonda , Suresh Kumar , Umed Singh , Priya Mahajan , Girish Mahajan , Amit Nargotra , Fayaz Malik , Dilip Manikrao Mondhe , Ram Asrey Vishwakarma , Parvinder Pal Singh
- Applicant: Council of Scientific and Industrial Research
- Applicant Address: IN New Delhi
- Assignee: Council of Scientific and Industrial Research
- Current Assignee: Council of Scientific and Industrial Research
- Current Assignee Address: IN New Delhi
- Agency: Schwegman Lundberg & Woessner, P.A.
- Priority: IN3369/DEL/2014 20141120
- International Application: PCT/IN2015/050169 WO 20151117
- International Announcement: WO2016/079760 WO 20160526
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; A61K31/53 ; A61K31/5377 ; A61P35/00 ; A61K31/519 ; A61K39/395
Abstract:
The present invention describes heterocyclic compounds of general Formula 1 and their method of preparation thereof. The present invention describes general Formula 1 which inhibits phosphoinositide 3-kinase (PI3K) and can be used as the anticancer agents.
Public/Granted literature
Information query
